Posterior reversible encephalopathy syndrome: Difference between revisions

(Text replacement - "==Diagnosis==" to "==Evaluation==")
(Text replacement - "HTN" to "hypertension")
Line 3: Line 3:
**[[Hypertensive Emergency|Hypertensive Encephalopathy]]
**[[Hypertensive Emergency|Hypertensive Encephalopathy]]
**Immunosuppresion
**Immunosuppresion
**[[Renal Failure|Uremia]] with HTN
**[[Renal Failure|Uremia]] with hypertension
*Newly recognized, described in 1996<ref> Hinchey J, et al. "A reversible posterior leukoencephalopathy syndrome". PMID 8559202</ref>
*Newly recognized, described in 1996<ref> Hinchey J, et al. "A reversible posterior leukoencephalopathy syndrome". PMID 8559202</ref>



Revision as of 10:52, 30 July 2016

Background

Clinical Features[2]

Differential Diagnosis[3]

Seizure

Evaluation

  • Focus on AMS workup, with PRES as diagnosis of exclusion
  • MRI shows cerebral edema, especially in posterior circulation[3]

Management

Disposition

Cardiac transplant patients are at high risk, with relative hypertension and on immunosuppressants

  • Admit

See Also

References

  1. Hinchey J, et al. "A reversible posterior leukoencephalopathy syndrome". PMID 8559202
  2. Staykov D. "Posterior reversible encephalopathy syndrome". PMID 21257628
  3. 3.0 3.1 Garg RK (January 2001). "Posterior leukoencephalopathy syndrome". Postgrad Med J 77 (903): 24–8. doi:10.1136/pmj.77.903.24. PMC 1741870. PMID 11123390